Adaptimmune Therapeutics Statistics
Total Valuation
ADAP has a market cap or net worth of $165.03 million. The enterprise value is $58.40 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADAP has 255.75 million shares outstanding. The number of shares has increased by 32.51% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 255.75M |
| Shares Change (YoY) | +32.51% |
| Shares Change (QoQ) | -1.58% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 22.42% |
| Float | 158.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| Forward PS | 3.53 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.93.
| Current Ratio | 3.85 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31.96 |
Financial Efficiency
Return on equity (ROE) is -52.96% and return on invested capital (ROIC) is -24.36%.
| Return on Equity (ROE) | -52.96% |
| Return on Assets (ROA) | -10.64% |
| Return on Capital (ROIC) | -24.36% |
| Revenue Per Employee | $389,846 |
| Profits Per Employee | -$99,145 |
| Employee Count | 449 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 44.88 |
Taxes
In the past 12 months, ADAP has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.77% in the last 52 weeks. The beta is 2.25, so ADAP's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +38.77% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 38.60 |
| Average Volume (20 Days) | 2,396,385 |
Short Selling Information
| Short Interest | 5.35M |
| Short Previous Month | 5.56M |
| Short % of Shares Out | 3.14% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.71 |
Income Statement
In the last 12 months, ADAP had revenue of $175.04 million and -$44.52 million in losses. Loss per share was -$0.18.
| Revenue | 175.04M |
| Gross Profit | 104.05M |
| Operating Income | -52.26M |
| Pretax Income | -162.17M |
| Net Income | -44.52M |
| EBITDA | -41.00M |
| EBIT | -52.26M |
| Loss Per Share | -$0.18 |
Full Income StatementBalance Sheet
The company has $186.09 million in cash and $74.50 million in debt, giving a net cash position of $111.60 million or $0.44 per share.
| Cash & Cash Equivalents | 186.09M |
| Total Debt | 74.50M |
| Net Cash | 111.60M |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 79.99M |
| Book Value Per Share | 0.31 |
| Working Capital | 180.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.68 million and capital expenditures -$1.49 million, giving a free cash flow of -$55.17 million.
| Operating Cash Flow | -53.68M |
| Capital Expenditures | -1.49M |
| Free Cash Flow | -55.17M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
Gross margin is 59.44%, with operating and profit margins of -29.86% and -25.43%.
| Gross Margin | 59.44% |
| Operating Margin | -29.86% |
| Pretax Margin | -24.73% |
| Profit Margin | -25.43% |
| EBITDA Margin | -23.42% |
| EBIT Margin | -29.86% |
| FCF Margin | -751.61% |